SWARTZ ROBIN (Chief Operating Officer) sold 1.7% of their position (1.26K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/5/2023ACC: 0001104659-23-042228
Officer· Chief Operating Officer
Since Feb 2022
-1.26K
Net shares
Net seller
$9.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.26K
Price / share
$7.83
Trade value
$9.86K
% of position
1.7%
4/3/2023
72.88K→71.62K
Total
Net shares
−1.26K
Net value
-$9.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2023 | S · Sale | −1.26K | $7.83 | $9.86K | 1.7% | 72.88K | 71.62K |
| Total | −1.26K | -$9.86K | ||||||
Derivative Transactions0
No derivative transactions reported